A carregar...

Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring.

In a longitudinal study of the evolution of serum beta 2-microglobulin (beta 2-m) levels in 37 patients with myelomatosis, those patients with a level of < 4 mg/l at first presentation had a median survival of 46 months, whereas those with an initial level of > mg/l had a median survival of 15...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Norfolk, D., Child, J. A., Cooper, E. H., Kerruish, S., Ward, A. M.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1980
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2010446/
https://ncbi.nlm.nih.gov/pubmed/6159910
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!